Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)

17.88
Delayed Data
As of Jun 23
 +0.58 / +3.35%
Today’s Change
13.01
Today|||52-Week Range
19.62
+29.28%
Year-to-Date
Company News for June 12, 2017
Jun 12 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close17.30
Today’s open17.26
Day’s range17.15 - 17.97
Volume859,649
Average volume (3 months)939,028
Market cap$1.9B
Dividend yield--
Data as of 4:00pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-2,620.00%
Earnings growth (this year)-5.11%
Earnings growth (next 5 years)+30.87%
Revenue growth (last year)-35.90%
P/E ratioNM
Price/Sales17.24
Price/Book11.85

Competitors

 Today’s
change
Today’s
% change
PCRXPacira Pharmaceutica...-0.40-0.84%
HZNPHorizon Pharma PLC-0.14-1.18%
SRPTSarepta Therapeutics...-0.46-1.30%
AERIAerie Pharmaceutical...-0.25-0.45%
Data as of 4:14pm ET, 06/23/2017

Financials

Next reporting dateAugust 1, 2017
EPS forecast (this quarter)-$0.44
Annual revenue (last year)$83.3M
Annual profit (last year)-$141.4M
Net profit margin-169.71%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Lonnel Coats
CFO, EVP-Corporate &
Administrative Affairs
Jeffrey L. Wade
Corporate headquarters
The Woodlands, Texas

Forecasts